Comparison of Laryngeal Mask and Tracheal Intubation With and Without Topical Lidocaine Application
1 other identifier
observational
150
1 country
1
Brief Summary
The study aims to identify the advantages and disadvantages of each of the three methods of airway management during FESS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
April 30, 2026
April 1, 2026
9 months
April 16, 2026
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cough severity and frequencies
Coughing was scored as mild (single cough), moderate (\>1 episode of un- sustained coughing lasting 5 seconds), or severe (sustained, \>5 seconds, bouts of coughing). Target values - mild cough.
15 minutes after waking up
Secondary Outcomes (2)
Richmond agitation-sedation scale (RASS)
15 minutes after waking up
The Ramsay scale
15 minutes after waking up
Study Arms (3)
LMA (1)
the laryngeal mask was installed intraoperatively
TI (2)
tracheal intubation was performed intraoperatively
TIL (3)
intraoperative tracheal intubation and respiratory tract anesthesia were performed
Interventions
administration of 4% lidocaine during tracheal intubation
Eligibility Criteria
adult patients who underwent FESS under general anesthesia
You may qualify if:
- general anesthesia during fess
You may not qualify if:
- history of mental and neurological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pavlov First Saint Petersburg State Medical University
Saint Petersburg, 197022, Russia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Assistant professor
Study Record Dates
First Submitted
April 16, 2026
First Posted
April 23, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
only statistical processing of an unnamed data array is planned